Literature DB >> 21459126

The role of ghrelin in GH secretion and GH disorders.

Ralf Nass1, Bruce D Gaylinn, Michael O Thorner.   

Abstract

In humans, growth hormone (GH) is secreted from the anterior pituitary in a pulsatile pattern. The traditional view is that this secretory pattern is driven by two counter regulatory neurohormones, GHRH and somatostatin. Ghrelin, the natural ligand for the growth hormone (GH)-secretagogue receptor (GHS-R), is produced in the stomach. Ghrelin is the strongest GH secretagogue known to date, but the role of endogenous ghrelin in the regulation of circulating GH levels remains controversial. The following review examines the evidence suggesting that endogenous ghrelin may be a key regulator of GH peak amplitude and discusses studies of diseases with altered GH levels, where it is found that in these states GH and ghrelin levels change in a similar way.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21459126      PMCID: PMC4205082          DOI: 10.1016/j.mce.2011.03.021

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  59 in total

1.  Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

Authors:  C B Webb; M L Vance; M O Thorner; G Perisutti; J Thominet; J Rivier; W Vale; L A Frohman
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

2.  Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor.

Authors:  Yuxiang Sun; Pei Wang; Hui Zheng; Roy G Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-18       Impact factor: 11.205

3.  Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.

Authors:  Polyxeni Koutkia; Bridget Canavan; Jeff Breu; Martin Torriani; John Kissko; Steven Grinspoon
Journal:  JAMA       Date:  2004-07-14       Impact factor: 56.272

4.  Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction.

Authors:  T Williams; M Berelowitz; S N Joffe; M O Thorner; J Rivier; W Vale; L A Frohman
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

5.  Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway.

Authors:  Alexandra M Nanzer; Sahira Khalaf; Abdul M Mozid; Robert C Fowkes; Mayur V Patel; Jacky M Burrin; Ashley B Grossman; Martá Korbonits
Journal:  Eur J Endocrinol       Date:  2004-08       Impact factor: 6.664

6.  Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.

Authors:  Paula Alvarez-Castro; Maria Luisa Isidro; Jesús Garcia-Buela; Alfonso Leal-Cerro; Fabio Broglio; Francesco Tassone; Ezio Ghigo; Carlos Dieguez; Felipe F Casanueva; Fernando Cordido
Journal:  Clin Endocrinol (Oxf)       Date:  2004-08       Impact factor: 3.478

7.  Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men.

Authors:  Polyxeni Koutkia; Bridget Canavan; Jeff Breu; Michael L Johnson; Steven K Grinspoon
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-11       Impact factor: 4.310

Review 8.  Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.

Authors:  Aart J van der Lely; Matthias Tschöp; Mark L Heiman; Ezio Ghigo
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

9.  The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture.

Authors:  Mark A Bach; Kenneth Rockwood; Carl Zetterberg; Gorm Thamsborg; Réjean Hébert; Jean-Pierre Devogelaer; Jens Sandahl Christiansen; René Rizzoli; J Lockwood Ochsner; Norman Beisaw; Oscar Gluck; Leisure Yu; Thomas Schwab; Jeanne Farrington; Alice M Taylor; Jennifer Ng; Vivian Fuh
Journal:  J Am Geriatr Soc       Date:  2004-04       Impact factor: 5.562

Review 10.  Interrelations between sleep and the somatotropic axis.

Authors:  E Van Cauter; L Plat; G Copinschi
Journal:  Sleep       Date:  1998-09-15       Impact factor: 5.849

View more
  14 in total

1.  Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.

Authors:  Céline M'Kadmi; Jean-Philippe Leyris; Lauriane Onfroy; Céline Galés; Aude Saulière; Didier Gagne; Marjorie Damian; Sophie Mary; Mathieu Maingot; Séverine Denoyelle; Pascal Verdié; Jean-Alain Fehrentz; Jean Martinez; Jean-Louis Banères; Jacky Marie
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

2.  Profound hypoglycemia in starved, ghrelin-deficient mice is caused by decreased gluconeogenesis and reversed by lactate or fatty acids.

Authors:  Robert Lin Li; Daniel P Sherbet; Benjamin L Elsbernd; Joseph L Goldstein; Michael S Brown; Tong-Jin Zhao
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

3.  Reduced autophagy in livers of fasted, fat-depleted, ghrelin-deficient mice: reversal by growth hormone.

Authors:  Yuanyuan Zhang; Fei Fang; Joseph L Goldstein; Michael S Brown; Tong-Jin Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

4.  Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone.

Authors:  Krystal A Irizarry; James Bain; Merlin G Butler; Olga Ilkayeva; Michael Muehlbauer; Andrea M Haqq; Michael Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2015-04-01       Impact factor: 3.478

Review 5.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

6.  Insulinlike Growth Factor Binding Protein-1 and Ghrelin Predict Health Outcomes Among Older Adults: Cardiovascular Health Study Cohort.

Authors:  Robert C Kaplan; Garrett Strizich; Chino Aneke-Nash; Clara Dominguez-Islas; Petra Bužková; Howard Strickler; Thomas Rohan; Michael Pollak; Lewis Kuller; Jorge R Kizer; Anne Cappola; Christopher I Li; Bruce M Psaty; Anne Newman
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

7.  Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice.

Authors:  Cibele N Peroni; Cesar Y Hayashida; Nancy Nascimento; Viviane C Longuini; Rodrigo A Toledo; Paolo Bartolini; Cyril Y Bowers; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

8.  A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.

Authors:  Daren K Heyland; Arthur R H van Zanten; Teodoro Grau-Carmona; David Evans; Albertus Beishuizen; Jeroen Schouten; Oscar Hoiting; Maria Luisa Bordejé; Kenneth Krell; David J Klein; Jesus Gonzalez; Aitor Perez; Randy Brown; Joyce James; M Scott Harris
Journal:  Intensive Care Med       Date:  2019-05-06       Impact factor: 41.787

Review 9.  Structure and physiological actions of ghrelin.

Authors:  Christine Delporte
Journal:  Scientifica (Cairo)       Date:  2013-11-28

10.  LEAP-2/ghrelin interplay in adult growth hormone deficiency: Cause or consequence? A pilot study.

Authors:  Edoardo Vergani; Carmine Bruno; Cesare Gavotti; Luigi Simone Aversa; Maria Martire; Antonio Mancini; Diego Currò
Journal:  IUBMB Life       Date:  2021-05-28       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.